Compare Mercadolibre Inc (MELI) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mercadolibre Inc vs Tempus AI — how do they compare? Mercadolibre Inc trades at $1,854.25 (market cap $94.94B), while Tempus AI trades at $70.48 (market cap $12.77B). The key difference: Mercadolibre Inc is far larger — about 7.4× Tempus AI's market cap, and Mercadolibre Inc is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Mercadolibre Inc for 117 Days and Tempus AI for 22 Days on average.
| MELI | TEM | |
|---|---|---|
Market Cap | $94.94B | $12.77B |
Volume | 428,337 | 8,980,490 |
Sector | Consumer Cyclical | Broad Market / Factor |
52-Week High | $2.36K | $99.28 |
52-Week Low | $1.55K | $41.55 |
Typical Hold Time | 117 Days | 22 Days |
Enterprise Value | $102.59B | $13.40B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MercadoLibre (MELI) trades at $1,856.66, down slightly by 0.07% on the day, with a bullish technical signal from moving averages and strong institutional support. The company reported $28.89 billion in revenue for 2025, with net income of $2.00 billion, though profit margins have softened from 9.19% in 2024 to 6.91%. Recent news highlights expansion in Brazil, including one-hour delivery and pharmacy growth, while the fintech segment's credit portfolio surged 75% to $16.4 billion in Q2 2026.
The stock presents a growth opportunity with robust revenue expansion and dominant market position in Latin American e-commerce and fintech, but faces risks from macroeconomic pressures in key markets like Argentina and elevated valuation multiples. Analyst consensus is strongly bullish with a $2,170 price target, suggesting potential upside, though investors should weigh margin compression against ecosystem strength.
Tempus AI (TEM) trades at $70.29, down 2.35% on the day, with a bullish technical signal despite negative profitability. Recent FDA clearance for its ECG-MR AI product and 13 abstracts accepted for ESMO Congress 2026 highlight ongoing innovation. Revenue grew to $1.4B in 2026, though net losses persist. The stock shows strong analyst support with a $72.60 consensus target and 64% buy ratings.
Outlook remains cautiously optimistic driven by AI healthcare adoption and data licensing growth, but high valuation multiples and sustained losses pose risks. Investor sentiment is positive amid recent insider selling and institutional interest, yet profitability challenges and competitive pressures require monitoring for long-term value creation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Mercadolibre Inc
MercadoLibre runs the largest e-commerce marketplace in Latin America, connecting a network of more than 140 million active users and 1 million active sellers as of the end of 2021 across an 18-country footprint. The company also operates a host of complementary businesses, with shipping solutions (Mercado Envios), a payment and financing operation (Mercado Pago), advertisements (Mercado Clics), classifieds, and a turnkey e-commerce solution (Mercado Shops) rounding out its arsenal. MercadoLibre generates revenue from final value fees, advertising royalties, payment processing, insertion fees, subscription fees, and interest income from consumer and small-business lending.
Read more on MELI →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
